Phase 3 Readout~month

Phase 3 Topline: An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundro

Indication
Hypertension

Other upcoming events for MLYS

PDUFA DatePDUFA Date: lorundrostat

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundro — MLYS Phase 3 Readout | BioSniper